Encephalitis, Japanese B Completed Phase 4 Trials for Japanese encephalitis vaccine (live, attenuated) (DB16577)

Also known as: Japanese Encephalitis / Encephalitis Japanese B / Encephalitis, Japanese / Japanese B encephalitis / Japanese B viral encephalitis

Indication	Status	Phase
DBCOND0033957 (Encephalitis, Japanese B)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01981967	Post-licensure Safety Study of IMOJEV® in Thailand	Prevention	Japanese encephalitis vaccine (live, attenuated) (DB16577)
NCT02514746	Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose	Prevention	Japanese encephalitis vaccine (live, attenuated) (DB16577)
NCT02880865	Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine	Prevention	Japanese encephalitis vaccine (live, attenuated) (DB16577) Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769) Measles virus vaccine live attenuated (DB10315) Mumps virus strain B level jeryl lynn live antigen (DB10316) Rubella virus vaccine (DB10317)